Introduction
Desmoidtumorsaredefinedas'clonalfibroblasticproliferationsthatariseinthedeepsofttissuesandarecharacterized byinfiltrativegrowthandatendencytowardlocalrecurrence butaninabilitytometastasize'(WorldHealthOrganization). They may affect all sites including extremities, trunk, and abdomen [1] . Two different types of desmoid tumors are described: Besides sporadic tumors there is a relationship betweendesmoidsandfamilialadenomatouspolyposis(FAP; Gardnersyndrome) [2] [3] [4] .Here,agerm-linemutationofAPC (coding for the adenomatous polyposis coli (APC) protein) predisposes patients to develop multiple colonic polyps and Onkologie2012 ;35: [684] [685] [686] [687] [688] [689] MolecularAnalysisofDesmoidTumors bySNPArray 685 extraintestinal neoplasms such as desmoids. Besides the involvement of APC in patients with FAP -where the germlineAPCmutationisfollowedbyinactivationofthewild-type APCallele-anassociationoftheAPC/beta-cateninpathway hasbeenreportedforsporadicdesmoidtumors [5] .
Moreover, the mutation status of the gene coding for catenin (cadherin-associated protein) beta 1 (CTNNB1) has animpactontheprognosisofpatientswithdesmoidtumors. Recentstudiesindicatethatatleast85%ofsporadicdesmoids showedmutationsinthisgene.Retrospectively,itwasfound thatoneofthem,theS45Fmutation,wasthemostimportant predictor of recurrence after surgery of the primary tumor, with a relative risk of 3.5 [6] . This represents the first documentation of a potentially clinically applicable molecular determinantofdesmoids [7] .
On the chromosomal level, recurrent cytogenetic alterationsincludetrisomy8,trisomy20,andlossofchromosome (Chr)5q.Thesecytogeneticalterationsaredescribedin3-30% ofalldesmoids.Mostoftheanalysesconductedthusfarwere performed by conventional cytogenetics or comparative genomic hybridization (CGH) arrays. Some authors describe a prognosticimpactofalterationssuchastrisomy8orDel5q [8] .
Inthepresentpilotstudy,wecarriedoutacomprehensive molecularanalysiswithahigh-densitysingle-nucleotidepolymorphism (SNP) array in order to elucidate new molecular mechanismsunderlyingtheseraretumors,addressingthefollowing question: Which submicroscopic deletions could be foundindesmoidtumors?
Materials and Methods

Patients and Samples
Thestudyincluded9patientswithdesmoidtumors.The patientcharacteristics(gender,age,tumorsite,treatments)aresummarizedintable1. Allpatientswerereferredtoouroutpatientservicewiththediagnosisofa desmoidtumor confirmedbyhistologyobtainedfromsurgicalspecimens. Tumor specimens were classified according to the Fédération nationale des centres de lutte contre le cancer (FNCLCC) system [9] . Informed consent was obtained from all patients according to the Declaration of Helsinki.Nucleicacidswereisolatedfromfrozensurgicalspecimenscollected at operation, after homogenization of the frozen samples using Cryoprep(Covaris,Woburn,MA,USA).
SNP Array Analysis and Validation
Genomic DNA for SNP array analyses was isolated from diagnostic tumor specimens with the ALLprep DNA/RNA kit (Qiagen, Hilden, Germany) and quality controlled by Nanodrop ND-1000 photometric measurementandevaluationbyconventionalagarosegelelectrophoresis. 500 ng of genomic DNA per sample was processed and hybridized accordingtotheGenomeWideHumanSNP6.0Arrayprotocolinstruc-tions (Affymetrix, Santa Clara, CA, USA). Raw intensity data was processed using the Genotyping Console 4.0 software (Affymetrix). GenotypingfileswereimportedintotheCNAG3.3softwaretoperform allele-specificcopynumberanalysisaspreviouslydescribed [10] [11] [12] ,using 270 anonymous reference samples generated by the international HapMap project. Known copy number polymorphisms were excluded from thedatabycomparisonwithknowncopynumberpolymorphismsregisteredintheUniversityofCaliforniaSantaCruz(UCSC)genomebrowser Table 1 Erben/Nowak/Sauer/Ströbel/Hofmann/ Hofheinz/Hohenberger/Kasper http://genome.ucsc.edu/.Putativelysomaticallyacquiredgenomicalterations were validated on exemplary lesions by performing allele-specific copy number analysis in matched-pair SNP 6.0 array analysis of DNA fromcorrespondinghealthytissuesamplesin5patients.
Mutational Analysis and Gene Expression Analyses
TheCTNNB1exon3wasamplifiedfromgenomicDNA(100ng)usingthe following primers: BCATF 5'-GGTCCTCTGTGAACTTGCTC-3' and BCATR5'-CATGTTCCATCATGGGGTCC-3'.Amplificationreactions were undertakenfor35cycleswithanannealingtemperatureof55°C.The sequencingreactionwasperformedusingthe amplificationprimers. In addition, mutation analyses of suspected lesions were carried out for CUB and Sushi multiple domains 1 (CSMD1) and APC by direct Sanger sequencing of genomic DNA as described for APC [13] . For CSMD1, primers were designed to amplify 500-bp-long fragments with a minimum of 30-40 bp of intronic flanking sequence or multiple over lapping sequences in the case of larger exons (primer available on request). Amplification reactions were undertaken for 32 cycles with an annealing temperature of 60°C. Polymerase chain reaction (PCR) products were analyzed by bidirectional direct sequencing using the amplification primers. Sequencing data were collected on an ABI3130 sequencer(AppliedBiosytems,FosterCity,CA,USA).
Genomiccopynumberalterations(CNAs)ofChr8q(CSMD1)and Chr 5q containing the APC gene were further validated by performing SYBR green quantitative real-time PCR analysis on genomic DNA of matchedhealthysamples,usingaRoche480LightCycler(Roche,Mannheim,Germany).Allmeasurementswereconductedintriplicate.Cycling program:15min95°C,15s94°C,30s55°C,30s70°C, 45cycles.
Results
Summary of Copy Number and Recurrent Chromosomal Aberrations
The high-density SNP array analysis of 9 desmoid samples yieldedatotalof38putativelysomaticallyacquiredgenomic CNAsconsistingof15heterozygousdeletions,23duplications oramplifications,andnocopynumberneutrallossofheterozygosity(CNLOH).Overall,100%ofthepatientsinthisco-hortshowedaCNA,withamedianof4(range:1-7;table2, onlinesupplementalmaterial). NumericalaberrationswerefoundonChrs20and6with eithertrisomy20(n=1)ormonosomy6(n=1).Inanother patient,lossof6qcouldbeobserved.Heterozygousdeletions weredetectedonChr5q(n=3),Chr10p(n=1)andChr13q (n=1).Thesemacroscopicaberrationslargerthan1Mbp(mega basepairs)couldbefoundin40%(4/9)ofthesamples(table1).
The most common recurrent macroscopic CNAs were detectedasheterozygousdeletionsonChr5q(33%;n=3/9) containing the APC locus (deletions ranged from 6.1 to 43Mbp).Fromthe3patientswiththisdeletion,2showeda localrecurrenceafter12and17months,respectively.1recur-rence after surgery could be observed in the remaining patients(table1).
Furthermore, a recurrent submicroscopic deletion on Chr 8p (44%; n = 4/9) between 0.26 and 0.56 Mbp was observed sharing an identical submicroscopic deletion of Chr 8p23.2 containing coding regions of CSMD1 (minimal deleted region 191 kb; fig. 1 ). In 3 of 4 patients with this deletion of Chr 8p23.2, a relapse was observed after 12, 16, and 17 months, respectively (table 1). Another recurrent micro deletionaffectedsmallregionsonChr10q11containing regionsoftheannexinA8variant(ANXA8,n=2). 
Validation of SNP Array Data, Mutational Analysis
Apart from changes encompassing broad genomic regions, numerousrecurrentgenomicmicrolesionssmallerthan1Mbp could be identified (table 1) . The most common recurrent microdeletion on Chr 8p23.2 (CSMD1) and the deletion of Chr5q(APClocus)wherevalidatedin3patientswithcorre-spondinghealthytissueavailablebyperformingquantitative real-time PCR on the genomic DNA to confirm the allelic lossofthisregion.Inaddition,mutationanalysisofexons4-6 oftheCSMD1 geneandoftheAPCgenewasperformedand revealed no new sequence variants ( fig. 1) . CTNNB1 mutations where detected in 55% (5/9) of patients as affecting codon41(n=4)andcodon45(n=1;table1).
Discussion
Little is known about chromosomal changes in desmoid tumors. In previous studies, which performed CGH analysis and classical karyotyping, most of the desmoids were described with a normal karyotype in 50-77% of the analyzed samples [8, 14] . Using high-density SNP array analysis, our observation showed copy number changes in every single tumor. However, in 40% of our patients, aberrations larger than1Mbpcouldbeobserved.Takingintoaccountthedifferent resolution of detection techniques such as conventional cytogeneticsandCGHarrays,theresultsarecomparablewith previousstudiesshowingthatstructuralandnumericalaberrationsappearedinasubsetofdesmoidpatients.
Inapreviousstudy,CGHlossofChr6or6q,Chr5q,gain ofChr20,andalterationofChr8qwereobservedwithafre-quency of 3-11% [8] and confirmed previous observations [15, 16] . However, in the literature, the frequency of these aberrationsisvariableforthelossinChrs6(10-20%)and5q (5-11%)andthegaininChrs8(3-30%)and20(7-30%).In addition, a prognostic impact of trisomy 8 was suggested in 1oftheseanalyses.Inourstudy,notrisomy8wasdetected. However, the small sample size and patient selection in this rareentitycouldexplaindiscrepancies.Inaddition,thedifferent analyses hampering comparison and the influence of cultureconditionsincytogeneticstudiescouldbeproposedas other reasons. Gain of Chr 8 and Chr 20 might be overestimatedbecauseminorabnormalcellcloneswithtrisomy8or 20couldhavebeenselectedforduringtissueculture [8, 14] . ThelossesofChr6andChr5qwerecomparableintheCGH and our SNP array study. However, few recurrent lesions couldbeobserved.
Inahighproportion(30%)ofpatients,adeletioninChr5q was seen. This lesion contains the APC gene. Two patients with 5q deletion exhibited a local recurrence after 12 and 17months,respectively.Only1patientwithoutthisdeletion relapsedduringfollow-upinourcohort.However,duetothe small sample size, this is observational. In a proportion of patients, desmoids are associated with FAP, and germ-line mutations in the APC gene are described [17, 18] . In our cohort,1patientsufferedfromFAP.Indesmoids,APCmutations are found between codons 1445 and 1578 [19] . Therefore,mutationanalysesoftheAPCgenewereperformedbut revealednounknownsequencevariant.Besidestheinvolvement of APC in patients with FAP -where the germ-line APC mutation is followed by inactivation of the wild-type APCallele-anassociationoftheAPC/beta-cateninpathway hasbeenreportedforsporadicdesmoidtumors [5] .
In the literature, the frequency of CTNNB1 mutation is reportedasbetween50-85%,andaprognosticimpactisdescribed [6, 20] .Inourseries,themutationfrequencyis55%. Duetothesmallpatientcohort,noprognosticdatacouldbe reportedinourseries.However,noneofthepatientsinour serieswasfoundtosimultaneouslyhaveaCTNNB1mutation andarecurrentdeletioninChr5q.Thisfindingisinlinewith a previous analysis that alterations in APC (Del 5q) and CTNNB1mutationsdonotoccursimultaneously [8] .
As pointed out, the development of desmoids could be linked to APC mutations and loss of 5q, which includes the APClocus.Therefore,ourfindingssupportpreviousreports oftheinvolvementofalterationsofAPCandtheWntpathway,namelyCTNNB1mutations,indesmoidtumorigenesis. Apart from these known aberrations, novel submicroscopic changesweredetectedinourpresentpilotseries.
The most frequent one of these alterations was a small heterozygous deletion on Chr 8p23.2 (n = 4) containing the codingregionofCSMD1.Thisgenespansover2Mbofgeno-micDNAandcontains71exons.Thegenecodesfora3565-amino acid protein consisting of 14 CUB and 28 Sushi domains. CSMD1 was predicted as a receptor for unknown ligandsinvolvedinsignaltransduction [21] .Itsgeneishighly expressedinthecentralnervoussystemofratsand,inaddition,itisalsoexpressedatlowerlevelsinareasofregenerative growth including epithelial cells of the gastrointestinal system,skin,andmammaryducts [10] .Lossofthispotential tumorsuppressorgenehasbeenobservedinseveralcancers suchasprostate [22] ,headandneck,breast [11, 23, 24] ,and coloncancer.Interestingly,thislesionhasnotbeendescribed previouslyindesmoidtumors.Theminimaldeletedregionin involvedpatientsincludes0.26Mbpcontainingexons4-6.Besidesthedeletionofthisgene,pointmutationsandepigenetic modificationleadingtolossofCSMD1transcriptshavebeen described [11, 12, 24] . Therefore, mutational analysis was performed, but no unknown sequence variant could be detected.Inaddition,aprognosticimpactofthislosson8p23
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is described in head and neck cancer and breast carcinoma [25, 26] . Our results showed an association of this loss with local recurrence.Becauseofthesmallpatientcohort,variable tumorlocalizations,andvariabletherapies,furthervalidation is needed to investigate the role of this inactivation and its prognosticvalueinthisrareentity.
Conclusions
We describe a comprehensive genomic profiling of DNA from patients with desmoids. In addition to the confirmed frequencyofknownaberrationssuchasChr5qdeletionsand CTNNB1 mutations, structural chromosomal changes (gain ofChrs8and20)werefoundinaminorityofcases.Anovel recurrent deletion containing the tumor suppressor gene CSMD1, which was frequent in relapsing patients, was detectedinourpilotseries.Therefore,ourdatamayhelptopro-
